Pharmacokinetic, Metabolomic, and Stability Assessment of Ganoderic Acid H Based Triterpenoid Enriched Fraction of <i>Ganoderma lucidum</i> P. Karst

<i>Ganoderma lucidum</i> P. karst is an edible fungus that is used in traditional medicine and contains triterpenoids as the major phytoconstituents. Ganoderic acids are the most abundant triterpenoids that showed pharmacological activity. As Indian varieties contain ganoderic acid H (GA...

Full description

Bibliographic Details
Main Authors: Mohd Hafizur Rehman Ansari, Washim Khan, Rabea Parveen, Sadia Saher, Sayeed Ahmad
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:Metabolites
Subjects:
Online Access:https://www.mdpi.com/2218-1989/12/2/97
_version_ 1797478161662869504
author Mohd Hafizur Rehman Ansari
Washim Khan
Rabea Parveen
Sadia Saher
Sayeed Ahmad
author_facet Mohd Hafizur Rehman Ansari
Washim Khan
Rabea Parveen
Sadia Saher
Sayeed Ahmad
author_sort Mohd Hafizur Rehman Ansari
collection DOAJ
description <i>Ganoderma lucidum</i> P. karst is an edible fungus that is used in traditional medicine and contains triterpenoids as the major phytoconstituents. Ganoderic acids are the most abundant triterpenoids that showed pharmacological activity. As Indian varieties contain ganoderic acid H (GA-H), we aimed to prepare GA-H-based triterpenoid enriched fraction (TEF) and evaluated its pharmacokinetics, metabolomics, and stability analysis. A high-performance liquid chromatography (HPLC) method was developed to quantify GA-H in TEF and rat plasma. Based on GA-H content, a stability assessment and pharmacokinetic study of TEF were also performed. After its oral administration to rats, TEF’s the metabolic pattern recognition was performed through ultra-performance liquid chromatography mass spectroscopy (UPLC–MS). The developed HPLC method was found to be simple, sensitive, precise (<15%), and accurate (>90% recovery) for the quantification of GA-H. Pharmacokinetic analysis showed that GA-H reached its maximum plasma concentration (C<sub>max</sub> 2509.9 ng/mL) within two hours and sustained quantifiable amount up to 12 h with a low elimination rate (K<sub>el</sub>) 0.05 L/h. TEF contained ten bioavailable constituents. The prepared TEF was found to be stable for up to one year at room temperature. The prepared TEF, enriched with ganoderic acid, is stable, contains bioavailable constituents, and can be explored as phytopharmaceuticals for different pharmacological properties. Highlights: (1). Preparation of triterpenoid enriched fraction (TEF) from Ganoderma lucidum. (2). Major triterpenoid in TEF is ganoderic acid H (GA-H). (3). TEF contains several bioavailable phytoconstituents. (4). TEF (considering only GA-H) is stable for up to one year at room temperature. (5). GA-H is rapidly absorbed and has high systemic exposure.
first_indexed 2024-03-09T21:28:03Z
format Article
id doaj.art-e6eb94a02bf140d8a80ddbfc191688ee
institution Directory Open Access Journal
issn 2218-1989
language English
last_indexed 2024-03-09T21:28:03Z
publishDate 2022-01-01
publisher MDPI AG
record_format Article
series Metabolites
spelling doaj.art-e6eb94a02bf140d8a80ddbfc191688ee2023-11-23T21:04:23ZengMDPI AGMetabolites2218-19892022-01-011229710.3390/metabo12020097Pharmacokinetic, Metabolomic, and Stability Assessment of Ganoderic Acid H Based Triterpenoid Enriched Fraction of <i>Ganoderma lucidum</i> P. KarstMohd Hafizur Rehman Ansari0Washim Khan1Rabea Parveen2Sadia Saher3Sayeed Ahmad4Bioactive Natural Product Laboratory, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi 110062, IndiaBioactive Natural Product Laboratory, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi 110062, IndiaBioactive Natural Product Laboratory, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi 110062, IndiaViral Research Development Laboratory, Department of Microbiology, J.N.M.C, A.M.U, Aligarh 202002, IndiaBioactive Natural Product Laboratory, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi 110062, India<i>Ganoderma lucidum</i> P. karst is an edible fungus that is used in traditional medicine and contains triterpenoids as the major phytoconstituents. Ganoderic acids are the most abundant triterpenoids that showed pharmacological activity. As Indian varieties contain ganoderic acid H (GA-H), we aimed to prepare GA-H-based triterpenoid enriched fraction (TEF) and evaluated its pharmacokinetics, metabolomics, and stability analysis. A high-performance liquid chromatography (HPLC) method was developed to quantify GA-H in TEF and rat plasma. Based on GA-H content, a stability assessment and pharmacokinetic study of TEF were also performed. After its oral administration to rats, TEF’s the metabolic pattern recognition was performed through ultra-performance liquid chromatography mass spectroscopy (UPLC–MS). The developed HPLC method was found to be simple, sensitive, precise (<15%), and accurate (>90% recovery) for the quantification of GA-H. Pharmacokinetic analysis showed that GA-H reached its maximum plasma concentration (C<sub>max</sub> 2509.9 ng/mL) within two hours and sustained quantifiable amount up to 12 h with a low elimination rate (K<sub>el</sub>) 0.05 L/h. TEF contained ten bioavailable constituents. The prepared TEF was found to be stable for up to one year at room temperature. The prepared TEF, enriched with ganoderic acid, is stable, contains bioavailable constituents, and can be explored as phytopharmaceuticals for different pharmacological properties. Highlights: (1). Preparation of triterpenoid enriched fraction (TEF) from Ganoderma lucidum. (2). Major triterpenoid in TEF is ganoderic acid H (GA-H). (3). TEF contains several bioavailable phytoconstituents. (4). TEF (considering only GA-H) is stable for up to one year at room temperature. (5). GA-H is rapidly absorbed and has high systemic exposure.https://www.mdpi.com/2218-1989/12/2/97triterpenoidganoderic acid Hquantitative analysisUPLC–MSstability
spellingShingle Mohd Hafizur Rehman Ansari
Washim Khan
Rabea Parveen
Sadia Saher
Sayeed Ahmad
Pharmacokinetic, Metabolomic, and Stability Assessment of Ganoderic Acid H Based Triterpenoid Enriched Fraction of <i>Ganoderma lucidum</i> P. Karst
Metabolites
triterpenoid
ganoderic acid H
quantitative analysis
UPLC–MS
stability
title Pharmacokinetic, Metabolomic, and Stability Assessment of Ganoderic Acid H Based Triterpenoid Enriched Fraction of <i>Ganoderma lucidum</i> P. Karst
title_full Pharmacokinetic, Metabolomic, and Stability Assessment of Ganoderic Acid H Based Triterpenoid Enriched Fraction of <i>Ganoderma lucidum</i> P. Karst
title_fullStr Pharmacokinetic, Metabolomic, and Stability Assessment of Ganoderic Acid H Based Triterpenoid Enriched Fraction of <i>Ganoderma lucidum</i> P. Karst
title_full_unstemmed Pharmacokinetic, Metabolomic, and Stability Assessment of Ganoderic Acid H Based Triterpenoid Enriched Fraction of <i>Ganoderma lucidum</i> P. Karst
title_short Pharmacokinetic, Metabolomic, and Stability Assessment of Ganoderic Acid H Based Triterpenoid Enriched Fraction of <i>Ganoderma lucidum</i> P. Karst
title_sort pharmacokinetic metabolomic and stability assessment of ganoderic acid h based triterpenoid enriched fraction of i ganoderma lucidum i p karst
topic triterpenoid
ganoderic acid H
quantitative analysis
UPLC–MS
stability
url https://www.mdpi.com/2218-1989/12/2/97
work_keys_str_mv AT mohdhafizurrehmanansari pharmacokineticmetabolomicandstabilityassessmentofganodericacidhbasedtriterpenoidenrichedfractionofiganodermalucidumipkarst
AT washimkhan pharmacokineticmetabolomicandstabilityassessmentofganodericacidhbasedtriterpenoidenrichedfractionofiganodermalucidumipkarst
AT rabeaparveen pharmacokineticmetabolomicandstabilityassessmentofganodericacidhbasedtriterpenoidenrichedfractionofiganodermalucidumipkarst
AT sadiasaher pharmacokineticmetabolomicandstabilityassessmentofganodericacidhbasedtriterpenoidenrichedfractionofiganodermalucidumipkarst
AT sayeedahmad pharmacokineticmetabolomicandstabilityassessmentofganodericacidhbasedtriterpenoidenrichedfractionofiganodermalucidumipkarst